Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsIndustry
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Phaos Technology (Cayman) (POAS) Debt to Equity (2023 - 2025)

Phaos Technology (Cayman) (POAS) debt to equity from Apr 30, 2023 to Apr 30, 2025. The current Phaos Technology (Cayman) (POAS) debt to equity is -6.63%. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Debt to Equity

Debt to Equity

Annual Debt to Equity change of Phaos Technology (Cayman) (POAS)

YearDebt to EquityChange
2025-6.63%
N/A
20240.00%
N/A
20230.00%
N/A

Comparison Phaos Technology (Cayman) (POAS) debt to equity with competitors

Phaos Technology (Cayman) (POAS) debt to equity is -6.63%.

TickerNameDebt to EquityUpside
ICCMIcecure Medical Ltd0.14%-102.17%
BSXBoston Scientific Corp0.16%-102.39%
MDTMedtronic Plc0.39%-105.88%
CATXPerspective Therapeutics Inc0.46%-106.99%
PODDInsulet Corporation1.43%-121.53%
TMDXTransmedics Group Inc3.04%-145.78%
SMLRSemler Scientific Inc4.35%-165.59%
NNOXNano X Imaging Ltd5.62%-184.71%
EWEdwards Lifesciences Corp5.80%-187.37%
NSYSNortech Systems Inc6.34%-195.57%
VMDViemed Healthcare Inc6.40%-196.47%
BWAYBrainsway Ltd9.64%-245.29%
BIOBio-Rad Laboratories Inc - Class A11.72%-276.69%
BIO-BBio-Rad Laboratories Inc - Class B11.72%-276.69%
SINTSINTX Technologies Inc11.73%-276.79%
QDELQuidelOrtho Corporation12.33%-285.84%
AVNSAvanos Medical Inc12.56%-289.30%
PRCTProcept BioRobotics Corp14.86%-324.05%
PROFProfound Medical Corp15.16%-328.50%
SIBNSI-BONE Inc19.89%-399.94%
LIVNLivaNova PLC23.55%-455.08%
XTNTXtant Medical Holdings Inc24.31%-466.54%
STESteris Plc26.53%-500.06%
BDMDBaird Medical Investment Holdings Ltd .27.81%-519.29%
KIDSOrthoPediatrics Corp30.29%-556.73%
UFPTUFP Technologies Inc31.36%-572.74%
INFUInfuSystem Holdings Inc33.44%-604.18%
NEOGNeogen Corp37.73%-668.90%
HYPRHyperfine Inc - Class A38.19%-675.81%
ZIMVZimVie Inc46.14%-795.65%
AORTArtivion Inc47.81%-820.77%
OFIXOrthofix Medical Inc50.86%-866.81%
MASIMasimo Corp57.29%-963.83%
ZBHZimmer Biomet Holdings Inc58.95%-988.80%
SNNSmith & Nephew plc62.90%-1048.40%
SYKStryker Corp64.07%-1066.00%
ABTAbbott Laboratories65.40%-1086.00%
BRKRBruker Corp67.41%-1116.27%
VTAKCatheter Precision Inc68.35%-1130.44%
IARTIntegra Lifesciences Holdings Corp68.77%-1136.86%
PHGKoninklijke Philips N.V.71.08%-1171.61%
IVFINVO Fertility Inc72.39%-1191.42%
VREXVarex Imaging Corp73.30%-1205.17%
ITGRInteger Holdings Corp73.75%-1211.98%
TMCITreace Medical Concepts Inc74.61%-1224.96%
SGHTSight Sciences Inc75.20%-1233.73%
LUNGPulmonx Corp81.54%-1329.36%
OMOutset Medical Inc86.79%-1408.57%
OWLTOwlet Inc - Class A89.32%-1446.74%
ENOVEnovis Corp89.78%-1453.60%
RPIDRapid Micro Biosystems Inc - Class A93.41%-1508.28%
GEHCGE HealthCare Technologies Inc94.95%-1531.52%
SENSSenseonics Holdings Inc104.59%-1676.94%
AHCOAdaptHealth Corp120.98%-1924.03%
BVSBioventus Inc - Class A144.03%-2271.54%
MYOMyomo Inc151.74%-2387.82%
HAEHaemonetics Corp153.78%-2418.53%
VEROVenus Concept Inc. Common Stock186.91%-2917.97%
CVRXCVRx Inc200.93%-3129.47%
TLSITriSalus Life Sciences Inc258.29%-3994.19%
CLPTClearPoint Neuro Inc263.49%-4072.61%
APYXApyx Medical Corp273.43%-4222.54%
ARAYAccuray Inc348.10%-5348.20%
ADGMAdagio Medical Holdings Inc399.51%-6123.40%
NPCENeuroPace Inc408.34%-6256.46%
TNDMTandem Diabetes Care Inc454.50%-6952.42%
STIMNeuronetics Inc462.10%-7066.98%
SSKNSTRATA Skin Sciences Inc527.82%-8057.90%
CTSOCytosorbents Corp772.97%-11754.04%
SNWVSanuwave Health Inc1116.00%-16925.78%
ESTAEstablishment Labs Holdings Inc1681.61%-25453.46%